Features | VJHemOnc

SOHO 2020 highlights

Held virtually, the 2020 Society of Hematologic Oncology (SOHO) annual meeting gave key updates on novel agents, CAR T-cell therapies…

EBMT 2020: Transplantation Top Picks

ASH clinical practice guidelines for treating AML in older adults

The American Society of Hematology (ASH) has worked in partnership with the McMaster GRADE Center to release new guidelines for…

FDA clears first in vitro diagnostic MRD assay for CLL

The U.S. Food and Drug Administration (FDA) has approved the first and only assay – clonoSEQ®, to screen and assess…

FDA approves brexucabtagene autoleucel for MCL

The Food and Drug Administration (FDA) has approved a new path of treatment for patients with mantle cell lymphoma (MCL)…

FDA gives the go-ahead for belantamab mafodotin in relapsed/refractory multiple myeloma

The U.S. Food and Drug Administration (FDA) has approved belantamab mafodotin-blmf (Blenrep®) for the treatment of patients with relapsed/refractory multiple…

EHA 2020 Top Picks

VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!

Genetic mutation signifies new MDS subtype

Published in Blood, a special report has proposed a new, distinct subtype of myelodysplastic syndromes (MDS) based on the presence…